Active	Status	Sponsor type	Region	Phase	Filter
5 Active 1 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Patel, Atul
NCT04967664: Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery	Recruiting	3	408	Europe, US	Qutenza (capsaicin) 8% topical system, capsaicin 0.04% topical system	Averitas Pharma, Inc.	Post Surgical Neuropathic Pain	10/24	05/25
NCT04804033: A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention	Terminated	2/3	535	US	BHV-3500 (zavegepant), Placebo	Pfizer	Migraine	03/24	03/24
NCT04845178: Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults	Active, not recruiting	2	797	Canada, US, RoW	ABP-450, prabotulinumtoxinA, Placebo, 0.9% sodium chloride, saline	AEON Biopharma, Inc., PPD	Migraine	06/24	09/24
Shirzadi, Shahin
NCT04845178: Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults	Active, not recruiting	2	797	Canada, US, RoW	ABP-450, prabotulinumtoxinA, Placebo, 0.9% sodium chloride, saline	AEON Biopharma, Inc., PPD	Migraine	06/24	09/24
Garza, David De Leon
NCT04845178: Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults	Active, not recruiting	2	797	Canada, US, RoW	ABP-450, prabotulinumtoxinA, Placebo, 0.9% sodium chloride, saline	AEON Biopharma, Inc., PPD	Migraine	06/24	09/24